CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.93
(3.33%)
HKD 0.93
(3.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 897.95 Million HKD | -34.29% |
| 2022 | 339.62 Million HKD | 1.06% |
| 2021 | 336.06 Million HKD | 35.59% |
| 2020 | 247.85 Million HKD | -34.14% |
| 2019 | 376.31 Million HKD | -32.28% |
| 2018 | 555.67 Million HKD | 31.12% |
| 2017 | 423.78 Million HKD | -10.86% |
| 2016 | 475.43 Million HKD | 14.29% |
| 2015 | 415.97 Million HKD | 0.52% |
| 2014 | 413.82 Million HKD | 5.48% |
| 2013 | 392.33 Million HKD | 0.49% |
| 2012 | 390.41 Million HKD | 55.84% |
| 2011 | 250.52 Million HKD | 3.66% |
| 2010 | 241.68 Million HKD | 3.53% |
| 2009 | 233.44 Million HKD | 190.28% |
| 2008 | -258.56 Million HKD | -514.28% |
| 2007 | 62.41 Million HKD | -57.34% |
| 2006 | 146.31 Million HKD | -46.65% |
| 2005 | 274.24 Million HKD | 21700.4% |
| 2004 | 1.25 Million HKD | 91.48% |
| 2003 | 657 Thousand HKD | 101.09% |
| 2002 | -60.47 Million HKD | -4.45% |
| 2001 | -57.89 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 408.43 Million HKD | 0.0% |
| 2023 Q2 | 123.86 Million HKD | 0.0% |
| 2023 Q4 | 99.98 Million HKD | 0.0% |
| 2023 FY | 223.16 Million HKD | -34.29% |
| 2022 Q4 | 108.18 Million HKD | 0.0% |
| 2022 Q2 | 131.73 Million HKD | 0.0% |
| 2022 FY | 339.62 Million HKD | 1.06% |
| 2021 Q2 | 169.15 Million HKD | 0.0% |
| 2021 FY | 336.06 Million HKD | 35.59% |
| 2021 Q4 | 67.45 Million HKD | 0.0% |
| 2020 Q2 | 203.01 Million HKD | 0.0% |
| 2020 FY | 247.85 Million HKD | -34.14% |
| 2020 Q4 | -118.26 Million HKD | 0.0% |
| 2019 FY | 376.31 Million HKD | -32.28% |
| 2019 Q4 | 9.72 Million HKD | 0.0% |
| 2019 Q2 | 269.72 Million HKD | 0.0% |
| 2018 Q4 | 128.17 Million HKD | 0.0% |
| 2018 FY | 555.67 Million HKD | 31.12% |
| 2018 Q2 | 254.55 Million HKD | 0.0% |
| 2017 FY | 423.78 Million HKD | -10.86% |
| 2017 Q2 | 215.03 Million HKD | 0.0% |
| 2017 Q4 | -32.42 Million HKD | 0.0% |
| 2016 FY | 475.43 Million HKD | 14.29% |
| 2016 Q4 | 66.08 Million HKD | 0.0% |
| 2016 Q2 | 250.95 Million HKD | 0.0% |
| 2015 FY | 415.97 Million HKD | 0.52% |
| 2015 Q2 | 155.2 Million HKD | 0.0% |
| 2015 Q4 | 123.46 Million HKD | 0.0% |
| 2014 FY | 413.82 Million HKD | 5.48% |
| 2014 Q2 | 181.23 Million HKD | 0.0% |
| 2014 Q4 | 129.19 Million HKD | 0.0% |
| 2013 Q2 | 191.48 Million HKD | 0.0% |
| 2013 FY | 392.33 Million HKD | 0.49% |
| 2013 Q4 | 129.5 Million HKD | 0.0% |
| 2012 FY | 390.41 Million HKD | 55.84% |
| 2012 Q4 | - HKD | 0.0% |
| 2012 Q2 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2011 FY | 250.52 Million HKD | 3.66% |
| 2011 Q4 | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2010 FY | 241.68 Million HKD | 3.53% |
| 2010 Q2 | - HKD | 0.0% |
| 2009 FY | 233.44 Million HKD | 190.28% |
| 2009 Q4 | - HKD | 0.0% |
| 2008 FY | -258.56 Million HKD | -514.28% |
| 2007 FY | 62.41 Million HKD | -57.34% |
| 2006 FY | 146.31 Million HKD | -46.65% |
| 2005 FY | 274.24 Million HKD | 21700.4% |
| 2004 FY | 1.25 Million HKD | 91.48% |
| 2003 FY | 657 Thousand HKD | 101.09% |
| 2002 FY | -60.47 Million HKD | -4.45% |
| 2001 FY | -57.89 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 67.76 Million HKD | -1225.04% |